Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.055 | 0.7 |